Evidence map›Paper›PMID 37566431›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023

Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial.

Gloria D Coronado, Denis B Nyongesa, Anne L Escaron, Amanda F Petrik, Jamie H Thompson, Dave Smith, Melinda M Davis, Jennifer L Schneider, Jennifer S Rivelli, Tanya Laguna and 1 more

Abstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Reach of Calls and Text Messages for Mailed FIT Outreach in the PROMPT Stepped-Wedge Colorectal Cancer Screening Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  10. Colorectal cancer screening.Proceedings (Baylor University. Medical Center) · 2024
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gloria D CoronadoKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0003-1130-6542
Denis B NyongesaKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0009-0006-7815-7966
Anne L EscaronAltaMed Health Services, Corporation, Los Angeles, California.ORCID 0000-0003-0717-0750
Amanda F PetrikKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0002-8891-6042
Jamie H ThompsonKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0003-3922-4880
Dave SmithKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0001-5296-6462
Melinda M DavisOregon Health & Science University, Portland, Oregon.ORCID 0000-0002-3293-5113
Jennifer L SchneiderKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0002-6095-7942
Jennifer S RivelliKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0009-0006-6598-1809
Tanya LagunaAltaMed Health Services, Corporation, Los Angeles, California.ORCID 0009-0005-9773-4098
Michael C LeoKaiser Permanente Center for Health Research, Portland, Oregon.ORCID 0000-0001-7052-8183

Funding

Participatory Research to Advance Colon Cancer PreventionU01MD010665 · NIMHD · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORONADO, GLORIA D · 2016 to 2020
$2.5M
NIMHD NIH HHS U01 MD010665
6 · The paper itself

Abstract

backgroundMailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening rates, yet little is known about how to optimize these programs for effectiveness and cost.

methodsPROMPT was a pragmatic, stepped-wedge, cluster-randomized effectiveness trial of mailed FIT outreach. Participants in the standard condition were mailed a FIT and received live telephone reminders to return it. Participants in the enhanced condition also received a tailored advance notification (text message or live phone call) and two automated phone call reminders. The primary outcome was 6-month FIT completion; secondary outcomes were any colorectal cancer screening completion at 6 months, implementation, and program costs.

resultsThe study included 27,585 participants (80% ages 50-64, 82% Hispanic/Latino; 68% preferred Spanish). A higher proportion of enhanced participants completed FIT at 6 months than standard participants, both in intention-to-treat [+2.8%, 95% confidence interval (CI; 0.4-5.2)] and per-protocol [limited to individuals who were reached; +16.9%, 95% CI (12.3-20.3)] analyses. Text messages and automated calls were successfully delivered to 91% to 100% of participants. The per-patient cost for standard mailed FIT was $10.84. The enhanced program's text message plus automated call reminder cost an additional $0.66; live phone calls plus an automated call reminder cost an additional $10.82 per patient.

conclusionsAdding advance notifications and automated calls to a standard mailed FIT program boosted 6-month FIT completion rates at a small additional per-patient cost. IMPACT: Enhancements to mailed FIT outreach can improve colorectal cancer screening participation. Future research might test the addition of educational video messaging for screening-naïve adults.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerHumansMass ScreeningMiddle AgedOccult BloodReminder SystemsTelephone

Identifiers

PMID37566431
PMCPMC13403684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.